Share on LinkedInShare on LinkedIn

ARTICLE · 10 JANUARY 2017

December 2016 Deal Round-Up

Cassels
Cassels
Contributor
Cassels

Cassels

Cassels Brock & Blackwell LLP is a Canadian law firm focused on serving the transaction, advocacy,...

View firm profile
Explore more from Cassels

The following is a summary of major deals in the life science space that closed or were announced in December 2016.

CanadaCorporate/Commercial Law

The following is a summary of major deals in the life science space that closed or were announced in December 2016.

December 2016 continued to see activity among cannabis stocks, but one of the most notable transactions was the launch of BlueRock Therapeutics by Bayer AG and Versant Ventures, Inc. with a combined Series A funding round of US $225 million.

MERGERS & ACQUISITIONS
Date: Announced December 1, 2016

Acquirer: Canopy Growth Corporation (TSX: CGC)

Target: Mettrum Health Corp. (TSXV: MT)

Deal size: Approx. CDN $430 million

Description: On December 1, 2016 Canopy Growth Corporation ("Canopy Growth") and Mettrum Health Corp. ("Mettrum") announced that they entered into a definitive arrangement agreement (the "Arrangement Agreement") under which Canopy Growth will acquire all of the issued and outstanding shares of Mettrum. The total transaction is valued at approximately CDN $430 million and will be satisfied by the issuance of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from